Is digital drug delivery going mainstream? In a new Molex and Phillips-Medisize survey of 215 pharma executives, nearly 90% said it’s “extremely or very important.” The survey also reveals current adoption and the perceived benefits and barriers of digital drug delivery. Use these critical insights to inform planning and decision making — and to stay ahead of this rapidly evolving, growing market.
Industry Intelligence From Our Experts
As a trusted, global leader for design, development and manufacturing solutions, Phillips-Medisize, a Molex company, has decades of experience and expertise that inform powerful perspectives on the healthcare trends, shifts and innovations that create opportunities for customers. From surveys and white papers to blogs and videos, our new Insights blog delivers thought-provoking content and valuable industry intelligence — with your needs in mind.
View Additional Healthcare Resources
Semi-reusable smart autoinjectors strike a meaningful balance between sustainability and product safety — the key concerns for connected health adoption. Read the blog to learn how smart medical devices will emerge as an essential connected health strategy in pharmaceutical drug delivery.
New on-body wearable injectors feature patient-centered design and eliminate the circuitry commonly found in earlier devices. Advanced designs allow for a lower profile and more reliable operation – which means safer, more comfortable experiences for patients. In our latest blog post, learn why next-gen OBIs are helping shape the future of connected healthcare.
Connected Health: Healthcare’s New Reality
From ensuring broadband access to leveraging smart device capabilities, connected health is poised to play a fundamental role in overcoming our healthcare system challenges. Manufacturing is leading the charge to enable change.
Digital drug delivery puts patients first and is set to transform the future of pharma. Paul Chaffin, President of Phillips-Medisize, a Molex company, shares findings from our recent survey to explain the powerful impact on patient outcomes and the future of device design.
Phillips-Medisize is consistently recognized for its global contributions to healthcare and MedTech innovation and development. We’re proud to share just a few of our most recent awards:
- Pharmapack Awards 2019, Best Innovation in Drug Delivery
- MedTech Speakthrough, Best Overall Connected Health Solution
- CPhi Pharma Awards, Excellence in Pharma Drug Delivery Devices
- SIP, Greater Suzhou Best Employer YCHP
Realize Your Vision
Product realization is an inherently unpredictable journey through new unknowns. The challenges of bringing next-generation products to market are magnified in highly regulated industries where even the tiniest inconsistency can impact efficacy and outcomes — which affects your brand and diminishes profit. Industry-leading innovation needs industry-leading expertise and laser focus on minimizing risk. Achieve fast, high-quality healthcare product realization with Phillips-Medisize.
Tap into the competitive value of our expertise, drawn from decades of collaborating with top healthcare OEMs.